PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by Up to 50%

Novo Nordisk announced significant reductions, up to 50%, in the U.S. list prices for its popular drugs Ozempic and Wegovy.

24 Feb, 19:19 — 24 Feb, 19:19
PostShare
Only 1 source covers this story